Emergent BioSolutions Inc.EBSNYSE
Loading
EPS Diluted Over TimeExpanding
Percentile Rank50
5Y CAGR-30.3%
Studio
Year-over-Year Change

Diluted earnings per share

5Y CAGR
-30.3%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM0.93+125.8%
2024-3.60+75.8%
2023-14.85-232.2%
2022-4.47-210.1%
20214.06-28.4%
20205.67+445.2%
20191.04-14.8%
20181.22-28.7%
20171.71+51.3%
20161.13-